跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INHIBITA - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
INHIBITA
Approved
STANDARD
INHIBITA
Delta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
86f0dbd7e39cc0b4
Company
Delta Pharma Limited
Type
Standard
Approval Details
Approval Id
86f0dbd7e39cc0b4
Drug Approval Philippines Name
INHIBITA
Product Name
INHIBITA
Registration Number
DR-XY39212
Brand Name
INHIBITA
Generic Name
OMEPRAZOLE
Dosage Form
Enteric Coated Capsule
Dosage Strength
40mg
Manufacturer
Delta Pharma Limited
Importer
Biomed Pharma, Inc.
Distributor
Biomed Pharma, Inc.
Issuance Date
29 January 2024
Expiry Date
23 March 2029
Pharmacologic Category
PROTON PUMP INHIBITOR
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
86f0dbd7e39cc0b4
Type
Standard
Back to Philippines FDA Approvals